RxDoctor Payments Data

David Plager, MD

Pediatric Ophthalmology and Strabismus Specialist · Indianapolis, INNPI 1922009083

Payments from drug & device makers

$177,423in general payments, 2019–2025

Across 22 payments — averaging $8064.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ocular Therapeutix, Inc.$175K
  • Travere Therapeutics, Inc.$3K
$400in research payments, 2019–2025

Across 1 payment — averaging $400.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ophtec USA, Inc.$400

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Ocular Therapeutix, Inc.18$174,799
Travere Therapeutics, Inc.4$2,624

How this compares

Too few pediatric ophthalmology and strabismus specialist providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$16,388
Medicare patients
22
Services billed
938

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatric ophthalmology and strabismus specialist in Indianapolis

Where these figures come from

Is this you, or does something look wrong? →